FDA Orange Book
Generic for Abilify Mycite Kit
Abilify Mycite Kit contains aripiprazole. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Abilify Mycite Kit is aripiprazole. 14 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Abilify Mycite Kit and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Abilify Mycite Kit products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 10MG | Discontinued | None | 14 | AB |
| tablet, oral | 15MG | Discontinued | None | 13 | AB |
| tablet, oral | 20MG | Discontinued | None | 13 | AB |
| tablet, oral | 2MG | Discontinued | None | 14 | AB |
| tablet, oral | 30MG | Discontinued | None | 13 | AB |
| tablet, oral | 5MG | Discontinued | None | 14 | AB |
NDA 207202, held by OTSUKA PHARMACEUTICAL CO LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic aripiprazole
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| ALEMBIC PHARMACEUTICALS LTD | 202101 | AB (A-rated, therapeutically equivalent) | April 28, 2015 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| HETERO LABS LTD UNIT V | 205064 | AB (A-rated, therapeutically equivalent) | April 28, 2015 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| TORRENT PHARMACEUTICALS LTD | 201519 | AB (A-rated, therapeutically equivalent) | April 28, 2015 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| AUROBINDO PHARMA LTD | 203908 | AB (A-rated, therapeutically equivalent) | October 8, 2015 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| AMNEAL PHARMACEUTICALS | 204838 | AB (A-rated, therapeutically equivalent) | June 17, 2016 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| AJANTA PHARMA LTD | 206174 | AB (A-rated, therapeutically equivalent) | September 12, 2016 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| SCIEGEN PHARMACEUTICALS INC | 206383 | AB (A-rated, therapeutically equivalent) | September 29, 2016 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| MACLEODS PHARMACEUTICALS LTD | 204111 | AB (A-rated, therapeutically equivalent) | October 7, 2016 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| ACCORD HEALTHCARE INC | 206251 | AB (A-rated, therapeutically equivalent) | December 7, 2016 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| ORBION PHARMACEUTICALS PRIVATE LTD | 202683 | AB (A-rated, therapeutically equivalent) | May 23, 2017 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| PRINSTON PHARMACEUTICAL INC | 205363 | AB (A-rated, therapeutically equivalent) | December 4, 2017 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| ALKEM LABORATORIES LTD | 207105 | AB (A-rated, therapeutically equivalent) | February 21, 2019 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| UNICHEM LABORATORIES LTD | 203025 | AB (A-rated, therapeutically equivalent) | December 1, 2021 | 10MG, 15MG, 20MG, 2MG, 30MG, 5MG |
| SUNSHINE LAKE PHARMA CO LTD | 213037 | AB (A-rated, therapeutically equivalent) | October 2, 2023 | 10MG, 2MG, 5MG |
Abilify Mycite Kit patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 11476952 | April 28, 2026 | Drug product | None | 207202 |
| 9125939 | July 28, 2026 | Method of use | U-1749 | 207202 |
| 7978064 | September 14, 2026 | Drug product | None | 207202 |
| 8759350 | March 2, 2027 | Method of use | U-1529 | 207202 |
| 9444503 | November 19, 2027 | Drug product | U-2169 | 207202 |
| 9119554 | December 16, 2028 | Drug product | None | 207202 |
| 9060708 | March 5, 2029 | Drug product | None | 207202 |
| 9258035 | March 5, 2029 | Drug product | None | 207202 |
| 8674825 | April 9, 2029 | Drug product | U-2170 | 207202 |
| 8956288 | July 6, 2029 | Drug product | U-2167 | 207202 |
| 10441194 | July 26, 2029 | Drug product | None | 207202 |
| 8945005 | August 19, 2029 | Drug product | U-2167 | 207202 |
| 9433371 | September 15, 2029 | Drug product | None | 207202 |
| 8718193 | December 5, 2029 | Drug product | None | 207202 |
| 9149577 | December 15, 2029 | Drug product | None | 207202 |
| 8847766 | March 29, 2030 | Drug product | U-2167 | 207202 |
| 8545402 | April 27, 2030 | Drug product | None | 207202 |
| 8114021 | June 21, 2030 | Drug product | None | 207202 |
| 11464423 | September 15, 2030 | Drug product | None | 207202 |
| 9941931 | November 4, 2030 | Drug product | None | 207202 |
| 8961412 | November 17, 2030 | Drug product | None | 207202 |
| 8258962 | November 25, 2030 | Drug product | None | 207202 |
| 8547248 | December 18, 2030 | Drug product | U-2167 | 207202 |
| 11229378 | July 11, 2031 | Drug product | None | 207202 |
| 9320455 | December 15, 2031 | Drug product | None | 207202 |
| 10517507 | June 13, 2032 | Drug product | None | 207202 |
| 9268909 | October 15, 2033 | Drug product | U-2168 | 207202 |
Questions
Is there a generic for Abilify Mycite Kit?
Yes. The generic name for Abilify Mycite Kit is aripiprazole. 14 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Abilify Mycite Kit?
The active ingredient in Abilify Mycite Kit is aripiprazole, per the FDA Orange Book.
When does the Abilify Mycite Kit patent expire?
The last patent listed for Abilify Mycite Kit in the Orange Book expires October 15, 2033. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.